Credit Suisse’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$915M Sell
5,791,703
-391,832
-6% -$62.4M 0.88% 13
2023
Q4
$969M Sell
6,183,535
-477,561
-7% -$73.2M 0.93% 13
2023
Q3
$1.04B Sell
6,661,096
-245,478
-4% -$40.5M 1.05% 11
2023
Q2
$1.14B Sell
6,906,574
-182,055
-3% -$29.4M 1.13% 11
2023
Q1
$1.1B Sell
7,088,629
-46,551
-0.7% -$7.52M 1.11% 10
2022
Q4
$1.26B Buy
7,135,180
+64,103
+0.9% +$11.1M 1.34% 6
2022
Q3
$1.16B Sell
7,071,077
-23,056
-0.3% -$3.9M 1.29% 9
2022
Q2
$1.26B Buy
7,094,133
+121,713
+2% +$21.7M 1.31% 8
2022
Q1
$1.24B Buy
6,972,420
+706,237
+11% +$120M 1.06% 10
2021
Q4
$1.07B Buy
6,266,183
+62,902
+1% +$10.3M 0.57% 26
2021
Q3
$1B Sell
6,203,281
-155,144
-2% -$26.5M 0.55% 25
2021
Q2
$1.04B Sell
6,358,425
-181,595
-3% -$30.1M 0.55% 26
2021
Q1
$1.07B Buy
6,540,020
+427,421
+7% +$69.2M 0.55% 26
2020
Q4
$962M Buy
6,112,599
+158,580
+3% +$23.4M 0.47% 30
2020
Q3
$886M Buy
5,954,019
+127,892
+2% +$18.9M 0.54% 25
2020
Q2
$819M Buy
5,826,127
+125,862
+2% +$18.3M 0.59% 20
2020
Q1
$747M Sell
5,700,265
-216,280
-4% -$30.7M 0.65% 25
2019
Q4
$863M Buy
5,916,545
+807,729
+16% +$110M 0.63% 20
2019
Q3
$661M Buy
5,108,816
+215,099
+4% +$28.3M 0.56% 22
2019
Q2
$682M Buy
4,893,717
+197,752
+4% +$27.4M 0.6% 16
2019
Q1
$656M Sell
4,695,965
-740,623
-14% -$99.2M 0.6% 17
2018
Q4
$702M Sell
5,436,588
-321,180
-6% -$44.8M 0.73% 15
2018
Q3
$796M Buy
5,757,768
+225,433
+4% +$30M 0.71% 17
2018
Q2
$671M Buy
5,532,335
+843,441
+18% +$105M 0.66% 15
2018
Q1
$601M Sell
4,688,894
-375,516
-7% -$50.8M 0.56% 23
2017
Q4
$708M Buy
5,064,410
+453,172
+10% +$63.1M 0.63% 21
2017
Q3
$600M Sell
4,611,238
-287,324
-6% -$38.1M 0.58% 20
2017
Q2
$648M Sell
4,898,562
-1,107,721
-18% -$141M 0.63% 21
2017
Q1
$748M Sell
6,006,283
-178,029
-3% -$21.3M 0.67% 16
2016
Q4
$712M Buy
6,184,312
+167,562
+3% +$19.4M 0.71% 13
2016
Q3
$711M Sell
6,016,750
-180,681
-3% -$21.9M 0.67% 19
2016
Q2
$752M Sell
6,197,431
-46,985
-0.8% -$5.34M 0.83% 12
2016
Q1
$676M Sell
6,244,416
-861,033
-12% -$89.1M 0.81% 10
2015
Q4
$730M Sell
7,105,449
-1,064,898
-13% -$107M 0.84% 6
2015
Q3
$763M Buy
8,170,347
+730,686
+10% +$70.7M 0.91% 7
2015
Q2
$725M Buy
7,439,661
+439,452
+6% +$44M 0.71% 12
2015
Q1
$704M Sell
7,000,209
-545,199
-7% -$55.4M 0.71% 14
2014
Q4
$789M Sell
7,545,408
-780,469
-9% -$82.2M 0.7% 15
2014
Q3
$887M Buy
8,325,877
+1,298,824
+18% +$135M 0.72% 11
2014
Q2
$735M Buy
7,027,053
+650,024
+10% +$65.7M 0.6% 14
2014
Q1
$626M Sell
6,377,029
-674,049
-10% -$62.5M 0.61% 17
2013
Q4
$646M Buy
7,051,078
+786,388
+13% +$72.5M 0.59% 17
2013
Q3
$543M Buy
6,264,690
+283,255
+5% +$25.4M 0.54% 22
2013
Q2
$514M Buy
+5,981,435
New +$508M 0.52% 24

Other funds holding JNJ

Credit Suisse's JNJ Position: Q1 2024 in Review

Credit Suisse reduced its Johnson & Johnson (JNJ) stake by 6.3% in Q1 2024, selling an estimated $62.4M and leaving 5,791,703 shares worth $915M. The position accounts for 0.88% of the portfolio, ranked #13.

Credit Suisse first reported a position in JNJ in Q2 2013 and has held it in 44 quarters since. The position peaked at $1.26B in Q4 2022. 3,848 funds tracked by Wall St. Rank hold JNJ as of Q1 2024.

  • Credit Suisse held 5,791,703 shares of Johnson & Johnson worth $915M as of Q1 2024.
  • Credit Suisse sold 391,832 Johnson & Johnson shares in Q1 2024, an estimated $62.4M.
  • Johnson & Johnson made up 0.88% of Credit Suisse's portfolio in Q1 2024, its #13 holding.
  • Credit Suisse first reported a position in Johnson & Johnson in Q2 2013 and has held it in 44 quarters since.
  • Credit Suisse's Johnson & Johnson position peaked at $1.26B in Q4 2022.
  • 3,848 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.